By reconstituting the gut microbiota in patients, FMT can enhance antigen presentation, promote effector T cell function, and improve both the tumor microenvironment and systemic immune responses, thereby increasing the effectiveness of immunotherapies such as PD-1 inhibitors. Here, PDCD1 is linked to neoplasm.